wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38747262-146F6BB6-534E-4F1E-BF4D-E5635B4E5FD7
Q38747262-146F6BB6-534E-4F1E-BF4D-E5635B4E5FD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38747262-146F6BB6-534E-4F1E-BF4D-E5635B4E5FD7
From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.
P2860
Q38747262-146F6BB6-534E-4F1E-BF4D-E5635B4E5FD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38747262-146F6BB6-534E-4F1E-BF4D-E5635B4E5FD7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28e82dff73741063b0f4cd2738e4e200ee3e4a7c
P2860
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.